Orbimed Advisors - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,690,986
-11.6%
1,244,945
-0.5%
0.44%
+3.8%
Q2 2023$23,395,009
+1.9%
1,251,0700.0%0.42%
-6.0%
Q1 2023$22,957,135
-7.3%
1,251,0700.0%0.45%
-4.9%
Q4 2022$24,771,186
-17.7%
1,251,0700.0%0.47%
-15.2%
Q3 2022$30,101,000
+90.4%
1,251,070
+44.4%
0.56%
+94.8%
Q2 2022$15,812,000
+99.0%
866,396
+139.8%
0.29%
+122.5%
Q1 2022$7,945,000
-0.3%
361,300
+66.5%
0.13%
+26.5%
Q4 2021$7,970,000217,0000.10%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders